Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
871,580
+797,580
+1,078% +$2.76M 0.69% 6
2025
Q4
$252K Buy
+74,000
New +$359K 0.11% 16
2023
Q3
Sell
-463,823
Closed -$2.02M 27
2023
Q2
$2.02M Sell
463,823
-458,222
-50% -$1.02M 0.52% 13
2023
Q1
$1.57M Sell
922,045
-159,667
-15% -$282K 0.41% 16
2022
Q4
$2.1M Sell
1,081,712
-18,999
-2% -$42.6K 0.47% 20
2022
Q3
$2.17M Sell
1,100,711
-50,048
-4% -$119K 0.39% 20
2022
Q2
$2.35M Sell
1,150,759
-50,000
-4% -$124K 0.52% 23
2022
Q1
$4.24M Buy
1,200,759
+59,658
+5% +$212K 0.73% 20
2021
Q4
$4.42M Sell
1,141,101
-305,865
-21% -$1.45M 0.5% 22
2021
Q3
$8.99M Buy
+1,446,966
New +$12.3M 1.14% 16

Other funds holding LFMD

B. Riley Financial's LFMD Position: Q1 2026 in Review

B. Riley Financial increased its LifeMD (LFMD) stake by 1,078% in Q1 2026, buying an estimated $2.76M and bringing the position to 871,580 shares worth $3.15M. The position accounts for 0.69% of the portfolio, ranked #6.

B. Riley Financial first reported a position in LFMD in Q3 2021 and has held it in 10 quarters since. The position peaked at $8.99M in Q3 2021. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • B. Riley Financial held 871,580 shares of LifeMD worth $3.15M as of Q1 2026.
  • B. Riley Financial bought 797,580 LifeMD shares in Q1 2026, an estimated $2.76M.
  • LifeMD made up 0.69% of B. Riley Financial's portfolio in Q1 2026, its #6 holding.
  • B. Riley Financial first reported a position in LifeMD in Q3 2021 and has held it in 10 quarters since.
  • B. Riley Financial's LifeMD position peaked at $8.99M in Q3 2021.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on B. Riley Financial's 13F filing for Q1 2026, filed 15 May 2026.